about the product
The drug Amklav® SAR® is a dispersible tablet that looks like:
- Dosage 125 mg + 31.25 mg: tablets from white to light yellow, oval, biconvex, marbling and the presence of single inclusions from light yellow to brown are allowed.
- Dosage 250 mg + 62.5 mg: tablets from white to light yellow, oval, biconvex, marbling and the presence of single inclusions from light yellow to brown are allowed.
- Dosage 500 mg + 125 mg: tablets from white to light yellow, oval, biconvex, marbling and the presence of single inclusions from light yellow to brown are allowed.
- Dosage 875 mg + 125 mg: tablets from white to light yellow, oval, biconvex, marbling and the presence of single inclusions from light yellow to brown are allowed.
Specifications
Name
Amklav®
Dosage form
Film-coated tablets
Nosological classification
Antibacterial drugs of systemic action
INN
Amoxicillin+[Clavulanic acid]
Dosages
500 mg + 125 mg; 875 mg + 125 mg; 250 mg + 125 mg
ATC code
J01CR02
Active substance
amoxicillin + [clavulanic acid]
Pharmacotherapeutic group
Antibacterial
use
Always take the drug in full accordance with the recommendations of your doctor. If in doubt, consult your doctor.
Recommended dose Your doctor will determine the dose for you individually, depending on your age, body weight, kidney function, and the severity of the infection. Recommended dose for adults: 1 tablet 500 mg + 125 mg 3 times a day. The maximum daily dose should not exceed 2,400 mg + 600 mg per day.
Special patient groups If you have kidney problems, your doctor may reduce the dose of the drug depending on your condition.
Use in children and adolescents
Children aged 1 to 12 years with a body weight of 10 to 40 kg
The recommended daily dose ranges from 20 mg / 5 mg/ kg per day to 60 mg / 15 mg/ kg per day and is divided into 2-3 doses. The doctor will calculate the exact dose individually, based on your child's condition, age and weight.
Children aged 12 years and older or with a body weight of 40 kg or more
1 tablet of 500 mg + 125 mg 3 times a day.
Route and method of administration The drug is taken orally. To prevent dyspeptic symptoms such as abdominal pain, burning sensation in the epigastrium, feeling of fullness after eating, bloating, the drug is recommended to be taken at the beginning of a meal. The tablet is dissolved in half a glass of water (at least 30 ml), stirring thoroughly before use.
Recommended dose Your doctor will determine the dose for you individually, depending on your age, body weight, kidney function, and the severity of the infection. Recommended dose for adults: 1 tablet 500 mg + 125 mg 3 times a day. The maximum daily dose should not exceed 2,400 mg + 600 mg per day.
Special patient groups If you have kidney problems, your doctor may reduce the dose of the drug depending on your condition.
Use in children and adolescents
Children aged 1 to 12 years with a body weight of 10 to 40 kg
The recommended daily dose ranges from 20 mg / 5 mg/ kg per day to 60 mg / 15 mg/ kg per day and is divided into 2-3 doses. The doctor will calculate the exact dose individually, based on your child's condition, age and weight.
Children aged 12 years and older or with a body weight of 40 kg or more
1 tablet of 500 mg + 125 mg 3 times a day.
Route and method of administration The drug is taken orally. To prevent dyspeptic symptoms such as abdominal pain, burning sensation in the epigastrium, feeling of fullness after eating, bloating, the drug is recommended to be taken at the beginning of a meal. The tablet is dissolved in half a glass of water (at least 30 ml), stirring thoroughly before use.
Help
Package leaflet
The drug Amklav® SAR® contains two active ingredients – amoxicillin and clavulanic acid. Amoxicillin is an antibiotic of the penicillin group: it kills bacteria that cause a number of infections. Some bacteria are able to produce enzymes called beta-lactamases that break down amoxicillin. Clavulanic acid blocks the action of such enzymes (beta-lactamase inhibitor) and thus prevents the destruction of amoxicillin.
The drug Amklav® SAR® is used in adults and children over 1 year of age or with a body weight of more than 10 kg to treat the following infections:
- ear, throat, and nose infections;
- respiratory infections (bronchi and lungs);
- urinary tract infections (kidneys and bladder);
- infections of the female genital organs;
- skin and soft tissue infections;
- infections of bones and joints;
- infections of the oral cavity;
- infections of the abdominal organs, including after childbirth and abortion;
- blood infections (sepsis) as part of step-by-step therapy.
Symptoms: nausea, vomiting, diarrhea, or seizures.
In case of an overdose, you may be prescribed additional medications and procedures to relieve the condition.
Like all medications, the drug Amklav® SAR® may cause undesirable reactions, but they do not occur in everyone.
Very common (may occur in more than 1 person out of 10):
- diarrhea (in adults).
- thrush (candidiasis is a fungal infection of the vagina, mouth, or skin folds);
- diarrhea (in children);
- nausea;
- vomiting.
- dizziness;
- headache;
- digestive disorders;
- changes in blood tests used to assess liver function (increased activity of liver enzymes aspartate aminotransferase (ACT), alanine aminotransferase (ALT));
- rash, itching;
- allergic skin reaction with redness (urticaria).
Do not take Amklav®. SAR®:
- If you are allergic to amoxicillin, clavulanic acid, penicillins, or any other components of the drug listed in section 6 of the leaflet.;
- if you have had a severe allergic reaction to other beta-lactam antibiotics (for example, cephalosporins, carbapenems, monobactams). Allergy symptoms may include, for example, skin rash, swelling of the face or neck.;
- if you have ever had liver problems or jaundice (yellowing of the skin and whites of the eyes) during treatment with this combination of antibiotics.
Tell your doctor that you are taking, have recently taken, or may start taking any other medications.
Some medications may interact with Amklav®. SAR®. These include:
- medications for the treatment of gout (probenecid, allopurinol). Gout is a disease in which uric acid accumulates in the body, in the joints and kidneys. With the combined use of the drug Amklav® SAR® with allopurinol may cause skin rash;
- Methotrexate (a drug for cancer and rheumatoid arthritis). Concomitant use may lead to increased adverse reactions of methotrexate;
- oral contraceptives (drugs to prevent pregnancy taken by ingestion). The drug Amklav® SAR® reduces the effectiveness of oral contraceptives;
- drugs that prevent blood clotting (oral anticoagulants, for example, acenocoumarol or warfarin). You need to take blood clotting tests more often (prothrombin time, international normalized ratio (INR));
- mycophenolate mofetil (a drug for the prevention of organ rejection after transplantation). Combined use with Amklav® SAR® may reduce the effectiveness of mycophenolate mofetil.
The holder of the registration certificate
JSC Biochemist, Russian Federation
15A Vasenko St., Saransk, 430030, Republic of Mordovia
Manufacturer
JSC Biochemist, Russian Federation
Address: 15A Vasenko str., Saransk, 430030, Republic of Mordovia
Phone: +7 (8342) 38 03 68
Email: biohimic@promomed.pro
Internet address: promomed.pro
The organization that accepts consumer claims
JSC Biochemist, Russian Federation
Address: 15A Vasenko str., Saransk, 430030, Republic of Mordovia
Phone number: 8 800 222 95 63; 8 800 777 86 04 ( around the clock)
Email: hot_line@promomed.pro
Store at temperatures below 25℃. Store in the original packaging (pack). Do not dispose (pour) the drug into the sewer
Do not give the drug to children under 1 year of age or with a body weight of less than 10 kg (due to the inability to provide a dosage regimen).
Refrain from driving vehicles and working with mechanisms, as well as engaging in activities that require concentration, because dizziness may occur when using the drug.
our partners
Where to buy
